{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:54:36Z","timestamp":1761396876285,"version":"3.34.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":73,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.amjms.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:10:01Z","timestamp":1723137001000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics of primary biliary cirrhosis - idiopathic inflammatory myopathy overlap syndrome: A single center study"],"prefix":"10.1016","author":[{"given":"Juan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingdong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0002","first-page":"211","article-title":"Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome","volume":"9","author":"Assandri","year":"2016","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0003","first-page":"317","article-title":"Systemic sclerosis-polymyositis overlap syndrome associated with autoimmune hepatitis and cerebral vasculitis","volume":"21","author":"Pamfil","year":"2012","journal-title":"J Gastrointest Liver Dis JGLD"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.005_bib0004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hch078","article-title":"Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study","volume":"97","author":"Watt","year":"2004","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"5","key":"10.1016\/j.amjms.2024.08.005_bib0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatol Baltim Md"},{"issue":"31","key":"10.1016\/j.amjms.2024.08.005_bib0006","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3748\/wjg.v19.i31.5131","article-title":"Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.005_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.amjms.2024.08.005_bib0008","first-page":"3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol Baltim Md"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.005_bib0009","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study","volume":"50","author":"Myers","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.005_bib0010","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjms.2024.08.005_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpg.2018.06.004","article-title":"Improving prognosis in primary biliary cholangitis - therapeutic options and strategy","volume":"34-35","author":"Harms","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0012","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1586\/17474124.2016.1121810","article-title":"Proposed therapies in primary biliary cholangitis","volume":"10","author":"Floreani","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.amjms.2024.08.005_bib0013","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCG.0000000000001120","article-title":"Factors associated with potential progressive course of primary biliary cholangitis: data from real-world US database","volume":"53","author":"Younossi","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194397","article-title":"Cardiac involvement in patients with primary biliary cholangitis: a 14-year longitudinal survey-based study","volume":"13","author":"Bian","year":"2018","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.amjms.2024.08.005_bib0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.amjms.2024.08.005_bib0016","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","article-title":"The evolving spectrum of polymyositis and dermatomyositis\u2013moving towards clinicoserological syndromes: a critical review","volume":"47","author":"Tansley","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.amjms.2024.08.005_bib0018","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11926-013-0359-6","article-title":"Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis","volume":"15","author":"Kiely","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"9388","key":"10.1016\/j.amjms.2024.08.005_bib0019","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"10.1016\/j.amjms.2024.08.005_bib0020","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1007\/s10067-021-05828-y","article-title":"Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry","volume":"40","author":"Zhang","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.amjms.2024.08.005_bib0021","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00296-019-04411-8","article-title":"Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies","volume":"39","author":"Maundrell","year":"2019","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.005_bib0022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","article-title":"Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort","volume":"29","author":"Hou","year":"2019","journal-title":"Neuromuscul Disord NMD"},{"issue":"4","key":"10.1016\/j.amjms.2024.08.005_bib0023","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.005_bib0024","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.005_bib0026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.amjms.2024.08.005_bib0028","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/BOR.0000000000000753","article-title":"Cardiac involvement in inflammatory myopathies and inherited muscle diseases","volume":"32","author":"Lilleker","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.005_bib0027","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1536\/ihj.17-204","article-title":"Diagnostic approach to cardiac involvement in idiopathic inflammatory myopathies: a strategy combining cardiac troponin I but not T assay with other methods","volume":"59","author":"Chen","year":"2018","journal-title":"Int Heart J"},{"issue":"13","key":"10.1016\/j.amjms.2024.08.005_bib0029","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjms.2024.08.005_bib0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.amjcard.2013.05.065","article-title":"Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations","volume":"112","author":"Ataklte","year":"2013","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.amjms.2024.08.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160181","article-title":"Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts","volume":"11","author":"Lin","year":"2016","journal-title":"PloS One"},{"issue":"36","key":"10.1016\/j.amjms.2024.08.005_bib0032","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.amjms.2024.08.005_bib0033","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.005_bib0034","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0035","first-page":"191","article-title":"Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis","volume":"135","author":"Uhl","year":"1974","journal-title":"Johns Hopkins Med J"},{"issue":"2","key":"10.1016\/j.amjms.2024.08.005_bib0036","first-page":"172","article-title":"Polymyositis associated with asymptomatic primary biliary cirrhosis","volume":"16","author":"Bondeson","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.amjms.2024.08.005_bib0037","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2169\/internalmedicine.47.0793","article-title":"Primary biliary cirrhosis complicated by polymyositis and pulmonary hypertension","volume":"47","author":"Honma","year":"2008","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0038","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/s10165-010-0397-0","article-title":"Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura","volume":"21","author":"Kurihara","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.amjms.2024.08.005_bib0039","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.semarthrit.2021.05.019","article-title":"Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody","volume":"51","author":"Zhang","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.amjms.2024.08.005_bib0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0041","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jbspin.2017.04.004","article-title":"Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies","volume":"85","author":"Mauhin","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.amjms.2024.08.005_bib0042","doi-asserted-by":"crossref","first-page":"405","DOI":"10.21037\/cdt.2020.03.04","article-title":"Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies","volume":"10","author":"Liu","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.amjms.2024.08.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac090","article-title":"Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease","author":"Gui","year":"2022","journal-title":"Rheumatol Oxf Engl"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T05:57:18Z","timestamp":1736056638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924013983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"alternative-id":["S0002962924013983"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.08.005","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of primary biliary cirrhosis - idiopathic inflammatory myopathy overlap syndrome: A single center study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}